Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix
Clinical trial NCT06810895 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06810895
- Sponsor
- Ding Ma
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-01
- Primary completion
- 2027-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.